Highlights
- The EMBRACE trial found no statistically significant difference between enhanced group prenatal care (eGPC) and enhanced individual prenatal care (eIPC) in reducing postpartum depressive symptoms.
- Both models led to small-to-moderate, clinically meaningful reductions in Patient Health Questionnaire-9 (PHQ-9) scores from baseline to 12 weeks postpartum.
- The study suggests that integrating resources to address social determinants of health—such as food, transportation, and childcare—is a vital component of perinatal mental health care for low-income populations.
Introduction: The Burden of Perinatal Depression in Vulnerable Populations
Perinatal depression remains one of the most common complications of pregnancy and the postpartum period, affecting approximately 1 in 7 individuals. However, these statistics mask significant disparities. Racial and ethnic minority populations, particularly those served by Medicaid, experience higher rates of depressive symptoms and lower rates of treatment engagement compared to their higher-income, white counterparts. These disparities are rarely biological; instead, they are driven by the complex interplay of social determinants of health (SDoH), including food insecurity, lack of reliable transportation, and limited access to culturally sensitive mental health resources.
The Evolution of Prenatal Care Models
Traditional prenatal care often focuses on clinical metrics—blood pressure, fetal growth, and laboratory results—with less emphasis on the psychosocial environment. To address this, group prenatal care (GPC) models, such as CenteringPregnancy, were developed to provide peer support and extended time with providers. While early studies suggested GPC might improve outcomes, evidence regarding its specific impact on depression has been mixed. The EMBRACE (Enhanced Models for Better health and Resilience through Antenatal Care Education) trial sought to determine whether an ‘enhanced’ version of group care could outperform an ‘enhanced’ version of individual care in a high-risk, Medicaid-eligible population.
The EMBRACE Trial: Comparative Effectiveness of Enhanced Care Models
The EMBRACE trial was a randomized clinical trial conducted across 10 Medicaid-serving clinics in California’s San Joaquin Valley. This region is characterized by high rates of poverty and significant health disparities, providing a rigorous environment to test interventions designed to mitigate the impact of SDoH.
Study Population and Setting
The trial enrolled 678 pregnant individuals (analyzed sample of 674) who were Medicaid-eligible and at less than 25 weeks’ gestation. The cohort was predominantly Latine (72.0%), reflecting the demographics of the region, and included Black (7.4%), white (11.4%), and multiracial (5.5%) participants. The mean age was 27 years. This demographic focus is critical, as these populations are often underrepresented in clinical trials yet carry the highest burden of perinatal mood disorders.
Defining the Interventions: eGPC vs. eIPC
The trial was unique in that both the control and intervention arms were ‘enhanced’ to ensure that all participants received a high standard of care that addressed psychosocial needs.
Enhanced Individual Prenatal Care (eIPC)
Participants in the eIPC group received traditional one-on-one visits with providers, but these visits were supplemented with tailored assessments. These assessments focused on specific clinical, oral health, substance use, and psychosocial needs, ensuring that individual risks were identified and addressed within the standard care framework.
Enhanced Group Prenatal Care (eGPC)
The eGPC model utilized the group format but added significant structural supports designed to remove barriers to attendance and well-being. These enhancements included:
- On-site childcare during sessions.
- Transportation stipends to ensure patients could reach the clinic.
- Free groceries provided at sessions to address food insecurity.
- Integrated perinatal mental health screening with immediate referral pathways.
- Information and navigation services for community resources.
Key Findings: A Surprising Equivalence
The primary outcome was the change in depressive symptom severity, measured by the PHQ-9, from baseline (mid-pregnancy) to 3 months postpartum. The results, analyzed between December 2024 and December 2025, revealed a nuanced picture of maternal mental health.
Primary Outcome: PHQ-9 Score Reductions
The study found no statistically significant difference in the reduction of depressive symptoms between the eGPC and eIPC groups. The Cohen d for between-group change was 0.1 (95% CI, -0.1 to 0.3; P = .45). Adjustments for baseline severity, history of mental health conditions, and language did not alter this finding.
Improvement Across Both Groups
While the trial did not find a ‘superior’ model, it did find that participants in both groups experienced significant improvements. The eGPC group showed a mean reduction in PHQ-9 scores of 2.2 points (Cohen d = -0.4), while the eIPC group showed a reduction of 1.6 points (Cohen d = -0.5). Both reductions were statistically significant (P < .001). This suggests that the 'enhancements' shared by both models—or the increased attention to psychosocial needs—may have been the driving force behind the improvement, rather than the format of delivery (group vs. individual).
Critical Interpretation: Why Both Models Succeeded
The lack of a significant difference between group and individual care in this trial is a major finding for health policy and clinical practice. It suggests that for low-income populations, the specific logistical and social supports provided may be more impactful than the peer-support element of group care alone.
Addressing Social Determinants of Health
By providing groceries, transportation, and childcare, the EMBRACE trial directly addressed the structural barriers that often prevent low-income individuals from focusing on their mental health. When a patient does not have to worry about how they will get to the clinic or what their children will eat that night, they may have more psychological bandwidth to engage with the health education and emotional support provided during prenatal visits.
The ‘Enhancement’ as a Common Denominator
It is possible that the ‘enhancements’ in the eIPC arm—specifically the tailored psychosocial assessments—raised the standard of individual care to a level that matched the benefits of the group model. In many previous studies, group care was compared to ‘standard’ individual care, which often lacks robust mental health screening or SDoH support. By elevating the control group (eIPC), the EMBRACE trial provides a more rigorous test of the group format’s intrinsic value.
Expert Commentary and Clinical Implications
From a clinical perspective, the EMBRACE trial suggests that healthcare systems should prioritize ‘enhanced’ care regardless of whether they utilize a group or individual model. For clinics that lack the space or staffing to implement group care, the findings are encouraging: individual care can be highly effective if it is paired with social support and rigorous screening.However, for health policy experts and Medicaid administrators, the challenge remains the funding of these enhancements. Currently, many Medicaid reimbursement models do not cover the costs of ‘non-medical’ interventions like grocery distribution or transportation stipends. The EMBRACE trial provides evidence that these investments are associated with measurable improvements in maternal mental health, which could lead to long-term cost savings by reducing the need for intensive psychiatric intervention and improving child outcomes.
Study Limitations
The researchers noted that the study was conducted in a specific geographic area (San Joaquin Valley) with a high Latine population, which may limit the generalizability to other regions or ethnic groups. Furthermore, the 12-week postpartum follow-up, while standard, may not capture the full trajectory of postpartum depression, which can persist or emerge up to a year after delivery.
Conclusion: Shaping the Future of Medicaid-Funded Prenatal Care
The EMBRACE trial reinforces the necessity of a holistic approach to prenatal care. In a population facing significant social and economic stressors, both enhanced group and individual care models were effective in reducing depressive symptoms. The takeaway for clinicians and policymakers is clear: to improve maternal mental health, we must look beyond the clinical exam table and address the lived realities of the patients. Whether through groups or individual visits, providing ‘enhanced’ care that accounts for social determinants is a powerful tool in the fight against perinatal depression.
Funding and ClinicalTrial.gov
This study was supported by the Patient-Centered Outcomes Research Institute (PCORI). ClinicalTrials.gov Identifier: NCT04154423.
References
1. Felder JN, León-Martínez D, Karasek D, et al. Enhanced Prenatal Care Models and Postpartum Depression: The EMBRACE Randomized Clinical Trial. JAMA Netw Open. 2026;9(2):e2559883. doi:10.1001/jamanetworkopen.2025.59883.
2. Biaggi A, Conroy S, Pawlby S, Pariante CM. Identifying the women at risk of antenatal anxiety and depression: A systematic review. J Affect Disord. 2016;191:62-77.
3. Gadson A, Akpovi E, Knight JR. Exploring-and-addressing-social-determinants-of-health-at-the-community-level. Med Care. 2018;56(9):750-756.